AAAAAA

   
Results: 1-13 |
Results: 13
FLAG IDARUBICIN FOR THE TREATMENT OF POOR-RISK MYELOID MALIGNANCIES/
Authors: ALREFAIE FN MILOJKOVIC D WONG THT PAGLIUCA A GRACE R MUFTI GJ
Citation: Fn. Alrefaie et al., FLAG IDARUBICIN FOR THE TREATMENT OF POOR-RISK MYELOID MALIGNANCIES/, British Journal of Haematology, 93, 1996, pp. 76-76
CHANGES IN TRANSFERRIN SATURATION AFTER TREATMENT WITH THE ORAL IRON CHELATOR DEFERIPRONE IN PATIENTS WITH IRON OVERLOAD
Authors: ALREFAIE FN DESILVA CE WONKE B HOFFBRAND AV
Citation: Fn. Alrefaie et al., CHANGES IN TRANSFERRIN SATURATION AFTER TREATMENT WITH THE ORAL IRON CHELATOR DEFERIPRONE IN PATIENTS WITH IRON OVERLOAD, Journal of Clinical Pathology, 48(2), 1995, pp. 110-114
RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS
Authors: ALREFAIE FN HERSHKO C HOFFBRAND AV KOSARYAN M OLIVIERI NF TONDURY P WONKE B
Citation: Fn. Alrefaie et al., RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS, British Journal of Haematology, 91(1), 1995, pp. 224-229
PHARMACOKINETICS OF THE ORAL IRON CHELATOR DEFERIPRONE (L(1)) IN PATIENTS WITH IRON OVERLOAD
Authors: ALREFAIE FN SHEPPARD LN NORTEY P WONKE B HOFFBRAND AV
Citation: Fn. Alrefaie et al., PHARMACOKINETICS OF THE ORAL IRON CHELATOR DEFERIPRONE (L(1)) IN PATIENTS WITH IRON OVERLOAD, British Journal of Haematology, 89(2), 1995, pp. 403-408
DEFERIPRONE-ASSOCIATED MYELOTOXICITY
Authors: ALREFAIE FN WONKE B HOFFBRAND AV
Citation: Fn. Alrefaie et al., DEFERIPRONE-ASSOCIATED MYELOTOXICITY, European journal of haematology, 53(5), 1994, pp. 298-301
DIFFERENTIAL TOXICITY OF ALPHA-KETO HYDROXYPYRIDINE IRON CHELATORS AND DESFERRIOXAMINE TO HUMAN HEMATOPOIETIC PRECURSORS IN-VITRO
Authors: CUNNINGHAM JM ALREFAIE FN HUNTER AE SHEPPARD LN HOFFBRAND AV
Citation: Jm. Cunningham et al., DIFFERENTIAL TOXICITY OF ALPHA-KETO HYDROXYPYRIDINE IRON CHELATORS AND DESFERRIOXAMINE TO HUMAN HEMATOPOIETIC PRECURSORS IN-VITRO, European journal of haematology, 52(3), 1994, pp. 176-179
ASSESSMENT OF HEPATIC IRON OVERLOAD IN THALASSEMIC PATIENTS BY MAGNETIC-RESONANCE SPECTROSCOPY
Authors: DIXON RM STYLES P ALREFAIE FN KEMP GJ DONOHUE SM WONKE B HOFFBRAND AV RADDA GK RAJAGOPALAN B
Citation: Rm. Dixon et al., ASSESSMENT OF HEPATIC IRON OVERLOAD IN THALASSEMIC PATIENTS BY MAGNETIC-RESONANCE SPECTROSCOPY, Hepatology, 19(4), 1994, pp. 904-910
ARTHROPATHY IN THALASSEMIA PATIENTS RECEIVING DEFERIPRONE
Authors: ALREFAIE FN WONKE B HOFFBRAND AV
Citation: Fn. Alrefaie et al., ARTHROPATHY IN THALASSEMIA PATIENTS RECEIVING DEFERIPRONE, Lancet, 344(8917), 1994, pp. 262-263
ZINC CONCENTRATION IN PATIENTS WITH IRON OVERLOAD RECEIVING ORAL IRONCHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE OR DESFERRIOXAMINE
Authors: ALREFAIE FN WONKE B WICKENS DG AYDINOK Y FIELDING A HOFFBRAND AV
Citation: Fn. Alrefaie et al., ZINC CONCENTRATION IN PATIENTS WITH IRON OVERLOAD RECEIVING ORAL IRONCHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE OR DESFERRIOXAMINE, Journal of Clinical Pathology, 47(7), 1994, pp. 657-660
THE EFFECT OF DEFERIPRONE (L(1)) AND DESFERRIOXAMINE ON MYELOPOIESIS USING A LIQUID CULTURE SYSTEM
Authors: ALREFAIE FN WILKES S WONKE B HOFFBRAND AV
Citation: Fn. Alrefaie et al., THE EFFECT OF DEFERIPRONE (L(1)) AND DESFERRIOXAMINE ON MYELOPOIESIS USING A LIQUID CULTURE SYSTEM, British Journal of Haematology, 87(1), 1994, pp. 196-198
RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS
Authors: HERSHKO C HOFFBRAND AV KOSARYAN M OLIVIERI NF ALREFAIE FN TONDURY P WONKE B
Citation: C. Hershko et al., RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS, Blood, 84(10), 1994, pp. 10000257-10000257
THE MECHANISM OF AGRANULOCYTOSIS MEDIATED BY THE ORAL IRON CHELATOR-L1
Authors: VEYS PA WILKES S ALREFAIE FN MILNE A MYINT A GORDONSMITH EC WONKE B HOFFBRAND AV
Citation: Pa. Veys et al., THE MECHANISM OF AGRANULOCYTOSIS MEDIATED BY THE ORAL IRON CHELATOR-L1, British Journal of Haematology, 84, 1993, pp. 64-64
AGRANULOCYTOSIS IN A PATIENT WITH THALASSEMIA MAJOR DURING TREATMENT WITH THE ORAL IRON CHELATOR, 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE
Authors: ALREFAIE FN VEYS PA WILKES S WONKE B HOFFBRAND AV
Citation: Fn. Alrefaie et al., AGRANULOCYTOSIS IN A PATIENT WITH THALASSEMIA MAJOR DURING TREATMENT WITH THE ORAL IRON CHELATOR, 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, Acta haematologica, 89(2), 1993, pp. 86-90
Risultati: 1-13 |